US Patent Issued to BioMadison on July 1 for "Peptides for characterization of botulinum neurotoxins" (Wisconsin Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,634, issued on July 1, was assigned to BioMadison Inc. (Del Mar, Calif.).

"Peptides for characterization of botulinum neurotoxins" was invented by Ward C. Tucker (Monona, Wis.) and Francis Mark Dunning (Madison, Wis.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Recombinant nucleic acids encoding reporting constructs for characterizing botulinum neurotoxin protease activity and cells that incorporate such recombinant nucleic acids and that are suitable for use in cell-based assays for the neurotoxin are provided. The encoded reporting constructs are a pair of recombinant hybrid proteins that act in concert, and can include an N-terminal palmitoylati...